The vice president warned governors and state Medicaid officials that federal funding for anti-fraud efforts could be cut unless states step up prosecutions, while the administration moves to withhold reimbursements from states it says are not taking fraud seriously.
Vice President JD Vance made the administration’s stance clear at a fraud-focused press event, laying out a hardline approach that links federal dollars to measurable anti-fraud action. He insisted the federal government has already poured billions into state Medicaid Fraud Control Units and that those investments demand results and accountability. The message was unmistakable: federal patience is limited when programs meant to help Americans are being drained by fraud. This is a fight framed as one of stewardship and basic government responsibility.
“We are sending letters that will require them to show that they are effectively and aggressively prosecuting Medicaid fraud in their states. And if they do not, if they do not aggressively prosecute Medicaid fraud, we are going to turn off the money that goes to these anti-fraud units,” said Vance during a fraud press conference on Wednesday. That line was not a threat tossed off; it was the centerpiece of a renewed push to make state leaders answerable for how they protect taxpayer-funded health programs. Enforcement, Vance argued, must be visible and consistent or funding will follow performance.
The administration immediately put its words into action by deferring $1.3 billion in Medicaid reimbursements to California, a move Vance said reflects a broader pattern of insufficient response to fraud. “We’re announcing that the federal government is deferring $1.3 billion in Medicaid reimbursements from the state of California. And the simple reason is because the state of California has not taken fraud very seriously,” Vance added. That decision signals that Washington will not tolerate token compliance when sizable sums are at risk.
Vance praised states that have moved aggressively to root out abuse, pointing to Ohio and Maryland as examples of jurisdictions cooperating with federal efforts. He highlighted concrete steps taken by state leaders, suggesting those actions should serve as a template for governors nationwide. Ohio’s response has been particularly proactive, with the governor announcing measures to clamp down on suspect home health and hospice enrollments. The administration wants every state to show that it can detect, investigate, and prosecute fraud, regardless of party control.
At the same time, Vance singled out several states for failing to meet the mark, calling out California, Hawaii, and New York for not taking the problem seriously enough. “This does not have to be a red state or a blue state issue. This is just basic good government. However, states like California, states like Hawaii, states like New York have completely not taken the fraud issue seriously in the Medicaid program and so for those states that refuse to get serious about fraud, we are going to turn off that anti-fraud money,” said Vance. That framing positions fraud enforcement as a commonsense, nonpartisan priority — even while the criticism lands hardest on some Democratic-led states.
Vance was explicit that turning off anti-fraud funding is not the preferred outcome; the goal is to spur action and protect beneficiaries and taxpayers. “We don’t want to turn off any money. What we want to do is ensure that people are taking fraud seriously. We want to protect Medicaid,” said Vance. “We want to protect Medicare, but we can’t do that if the states that are administering those programs are allowing those programs to be fleeced by fraudsters.” Those remarks underscore the practical stakes: unaddressed fraud weakens essential programs and harms vulnerable Americans who depend on them.
Separately, federal officials have been pressing states to revalidate providers deemed high-risk, a move designed to disrupt fraud schemes quickly by tightening enrollment and billing scrutiny. “While the factors contributing to fraud are multifaceted and require a comprehensive approach to address, a revalidation process for high-risk providers will immediately deter criminal actors from continuing their fraud schemes, as the federal and state governments closely review and scrutinize the qualifications of providers to suspend or terminate clearly abusive actors from the program,” Oz wrote in a letter. That revalidation push includes firm deadlines and asks states to lay out timetables for action.
The administration’s outreach has included follow-up letters to state Medicaid directors, urging a tailored revalidation strategy and stricter oversight of providers operating without standard identifiers. “Our analysis of national trends strongly suggests a persistent and growing Medicaid threat posed by sophisticated actors knowingly exploiting these complex systems for financial gain,” Oz wrote. Those findings shape a policy approach that combines immediate provider checks with longer-term enforcement partnerships between federal and state authorities.
For governors and Medicaid officials, the choice is straightforward: show aggressive, verifiable anti-fraud activity or risk losing targeted federal support designed to help states fight abuse. The administration is betting that the prospect of losing federal anti-fraud dollars will produce faster, tougher enforcement at the state level. If that pressure works, the stated goal is to protect program integrity and make sure taxpayer money goes to care, not criminals.
